Inborn errors in cholesterol (Chol) biosynthesis comprise a group of severe, often lethal, metabolic disorders, of which the Smith-Lemli-Opitz Syndrome (SLOS) -the fourth most prevalent recessive human disease - is the most well-known. Prior work has established a SLOS rat model, which exhibits a progressive retinal degeneration in which photoreceptors seem more susceptible than RPE cells or Muller glia. While the exact disease mechanism is not yet known, the initial biochemical defect involves inefficient conversion of 7- dehydrocholesterol (7DHC) to Chol, which is catalyzed by DHCR7 (3b-hydroxysterol-D7-reductase, the DHCR7 gene product). We have proposed that this leads to multiple sequelae, including altered gene expression, lipid and protein oxidation, caspase activation, and perturbed membrane structure, which then result in progressive cellular dysfunction and demise. 7DHC is the most oxygen-labile lipid known, and readily forms "oxysterols" (some of which are extraordinarily toxic to cells), and 7DHC-derived oxysterols tend to be more cytotoxic than are Chol-derived oxysterols. The native environment of the retina (high oxygen tension, iron, and incident light) presents ideal conditions for oxysterol formation. We hypothesize that the demonstrable rise in retina/RPE 7DHC levels with blockade of DHCR7 leads to in situ oxysterol formation, resulting in progressive dysfunction and death of photoreceptors, while RPE and Muller glia are relatively spared. Preliminary data strongly support this hypothesis, which we will test further via three Specific Aims: 1) Using transformed, retina-derived cell lines, we will examine whether 7DHC-derived oxysterols differentially alter gene expression and viability of photoreceptors, vs. RPE and Muller glia, in culture, and also will examine the protective effects of antioxidants;2) We will examine whether photoreceptors are more sensitive to intravitreally injected 7DHC- vs. Chol-derived oxysterols compared to other retinal cell types in vivo;and 3) We will examine the impact of cell-type specific disruption of cholesterol biosynthesis on retinal structure and function in vivo, selectively knocking out Dhcr7 in rods, RPE, or Muller glia. This will markedly advance our understanding of the SLOS-associated retinal degeneration mechanism, as well as provide new insights into the development of more effective therapeutic interventions for such diseases.

Public Health Relevance

The proposed studies will provide a mechanistic basis for understanding the pathobiology of retinal degeneration associated with the Smith-Lemli-Opitz syndrome (SLOS) and, by inference, allied cholesterol deficiency disorders, for which there currently are no cures and only partially effective treatments. If the hypothesis proves correct, blocking the formation of cytotoxic oxysterols (e.g., with a suitable antioxidant regimen) in conjunction with cholesterol supplementation would likely provide a markedly improved therapeutic intervention for such diseases.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
2R01EY007361-19
Application #
8260720
Study Section
Special Emphasis Panel (ZRG1-CB-G (02))
Program Officer
Shen, Grace L
Project Start
1988-03-01
Project End
2015-12-31
Budget Start
2012-01-01
Budget End
2012-12-31
Support Year
19
Fiscal Year
2012
Total Cost
$497,583
Indirect Cost
$75,831
Name
State University of New York at Buffalo
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Zhang, Sarah X; Sanders, Emily; Fliesler, Steven J et al. (2014) Endoplasmic reticulum stress and the unfolded protein responses in retinal degeneration. Exp Eye Res 125:30-40
Conley, Shannon M; Stuck, Michael W; Burnett, Justin L et al. (2014) Insights into the mechanisms of macular degeneration associated with the R172W mutation in RDS. Hum Mol Genet 23:3102-14
Sapkota, Darshan; Chintala, Hemabindu; Wu, Fuguo et al. (2014) Onecut1 and Onecut2 redundantly regulate early retinal cell fates during development. Proc Natl Acad Sci U S A 111:E4086-95
Rowan, Sheldon; Weikel, Karen; Chang, Min-Lee et al. (2014) Cfh genotype interacts with dietary glycemic index to modulate age-related macular degeneration-like features in mice. Invest Ophthalmol Vis Sci 55:492-501
Keller, R Kennedy; Mitchell, David A; Goulah, Christopher C et al. (2013) Hepatic isoprenoid metabolism in a rat model of Smith-Lemli-Opitz Syndrome. Lipids 48:219-29
Wu, Fuguo; Li, Renzhong; Umino, Yumiko et al. (2013) Onecut1 is essential for horizontal cell genesis and retinal integrity. J Neurosci 33:13053-65, 13065a
Xu, Libin; Sheflin, Lowell G; Porter, Ned A et al. (2012) 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Biochim Biophys Acta 1821:877-83
Xu, Jianhua; Morris, Lynsie M; Michalakis, Stylianos et al. (2012) CNGA3 deficiency affects cone synaptic terminal structure and function and leads to secondary rod dysfunction and degeneration. Invest Ophthalmol Vis Sci 53:1117-29
Li, Xiaoman; McClellan, Mark E; Tanito, Masaki et al. (2012) Loss of caveolin-1 impairs retinal function due to disturbance of subretinal microenvironment. J Biol Chem 287:16424-34
Carvalho, Livia S; Xu, Jianhua; Pearson, Rachael A et al. (2011) Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy. Hum Mol Genet 20:3161-75

Showing the most recent 10 out of 64 publications